HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - topoisomerase
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Topoisomerase
III (TOP3) Inhibitors as Antiviral and Anticancer Compounds based on Bisacridines
Abstract:
Topoisomerase
3B (TOP3B) is the only topoisomerase that can act on RNA as well as DNA. Thus, it is a target of interest for the development of cancer therapies and RNA viral infection therapies. TOP3B is not an essential gene for carcinogenesis, but a subset of cancer cells with pre-existing genome instability are particularly vulnerable to...
Published: 12/18/2024
|
Inventor(s):
Yves Pommier
,
Sourav Saha
,
Wenjie Wang
,
Shar-yin Huang
Keywords(s):
Bisacridines
,
CANCER
,
Pommier
,
SARS-CoV-2
,
TOP
,
TOP3
,
TOP3 Inhibitor
,
TOPOISOMERASE
,
Topoisomerase
III
,
Topoisomerase
Inhibitor
,
viral infection
Category(s):
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
Topoisomerase
III (TOP3) Inhibitors and Antiviral Compounds based on Cyanine Dyes
Topoisomerase
3B (TOP3B) is the only topoisomerase that can act on RNA as well as DNA, and thus has been a target of interest for the development of cancer therapies and RNA viral infection therapies. In the context of cancer, TOP3B is not an essential gene, but a subset of cancer cells with pre-existing genome instability are particularly vulnerable...
Published: 12/18/2024
|
Inventor(s):
Yves Pommier
,
Shar-yin Huang
,
Wenjie Wang
,
Weidong Wang
,
Sourav Saha
,
Tianyi Zhang
,
Mariano Garcia-Blanco
,
Pei-Yong Shi
,
Yuk-Ching Tse-Dinh
,
Debbie Kennedy-Boone
Keywords(s):
CANCER
,
Cyanine Dye
,
NIA
,
Pommier
,
SARS-CoV-2
,
TOP
,
TOP3
,
TOP3 Inhibitor
,
TOPOISOMERASE
,
Topoisomerase
III
,
Topoisomerase
Inhibitor
,
viral infection
,
Wang
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Oncology
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum